Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Drug Delivery
 More »

  • Nanoparticle Viewing Unit
    It does so particle-by-particle in the range 10-1,000 nm (material dependent). This can be used for protein aggregation, exosome and microvesicle research, and drug delivery ...
    5-15-2013
  • "A New Model in Clinical Development": Merck Serono Teams Up...
    The objective is to expedite the delivery of new therapeutic options to patients with high ... position in an increasingly challenging environment of clinical drug development." ...
    5-15-2013
  • Mirna Initiates PI Trial for miRNA Candidate Cancer Drug
    using a liposomal delivery formulation in-licensed from Marina Biotech. In a statement, Mirna CEO Paul Lammers called the trial "a landmark even for cancer drug development," ...
    5-13-2013
  • Recipharm, Synthonics Partner to Promote Drug Delivery Tech
    full access to the latter company's metal coordination chemistry, which has been shown to improve drug delivery and absorption. Financial terms of the agreement were not disclosed. ...
    5-7-2013
  • AZ Giving Way to Early-Stage Biopharmas in Cheshire
    The first three tenant companies were due to move on-site today-Blueberry Therapeutics, developer of nanopolymer delivery platforms for peptide-aptamer based drugs to treat drug-re...
    5-7-2013
  • Algeta Expands Cancer Drug Collaboration with Lumiphore
    Algeta will expand its three-year-old cancer drug collaboration with Lumiphore by taking ... molecules will benefit targeted delivery to cancer sites and has the potential to ...
    5-2-2013
  • Emergent, Caisson Collaborating to Optimize Heparosan Drug Delivery...
    Emergent Technologies and Caisson Biotech are teaming up in an effort to improve drug safety and efficacy using the latter firm's HEPtune(tm) drug delivery platform. With clinical ...
    5-1-2013
  • Comparative Genomics: Insights into Disease Susceptibility
    ... Using targeted delivery of RNA interference, to either disrupt (rats) or abolish (monkeys) ... comparative genomics, or highlight known drug metabolism variants. "Regardless of the ...
    5-1-2013
  • Advances in RNAi Tools and Technologies
    ... advances in siRNA synthesis and delivery have optimized the effectiveness of ... For example, the experimental sample may be treated with a cancer drug in order to look ...
    4-15-2013
  • Single-Use Bioreactor Roundup
    ... After delivery, the customers would then qualify the system for their needs and use it. ... use of single-use bioreactors in commercial drug manufacturing will grow significantly. ...
    4-15-2013
  • Astellas, Ambrx Launch Up-To-$300M ADC Partnership
    and highly stable conjugations that have the potential to further optimize drug delivery to tumor cells," David Stover, Ph.D., svp and Agensys site head, said in a statement. ...
    4-5-2013
  • Literature Review: A Flying Drop Becomes a Hanging Drop
    ... medicinal chemistry optimization during drug discovery, and this technique might make ... of 2-methyl-2,4-pentanediol (MPD) appeared to be systematically problematic in delivery. ...
    4-4-2013
  • Scientists Print 3D Materials Resembling Biological Tissues
    These printed "droplet networks" could, the authors say, form the building blocks of a new kind of technology for drug delivery, potentially replacing or interfacing with damaged ...
    4-4-2013
  • Is This Gene Therapy's Breakout Moment?
    ... It's an easier to develop a drug under those circumstances. While the criteria pharma uses ... That has to do with delivery-do we know what the gene should be? For a recessive genetic ...
    4-1-2013
  • Scaling Up Peptide Drugs
    ... Whereas many peptide drugs are injectables, advances in oral peptide drug delivery and in other delivery approaches such as transdermal, nasal, and depot formulations may ...
    4-1-2013
  • More »

    Journal Articles

  • Effect of Needle Diameter and Flow Rate on Rat and Human Mesenchymal...
    Peter A. Walker, Fernando Jimenez, Michael H. Gerber, Kevin R. Aroom, Shinil K. Shah, Matthew T. Harting, Brijesh S. Gill, Sean I. Savitz, Charles S. Cox
    Tissue Engineering, Part C: Methods
    with recently published Food and Drug Administration guidelines (viability >70%). ... These results ensure the biocompatibility of MSCs with commonly used delivery methods.
  • Next Generation of Electrosprayed Fibers for Tissue Regeneration
    Jong Kyu Hong, Sundararajan V. Madihally
    Tissue Engineering, Part B: Reviews
    possibility of tailoring the mechanical properties and biological properties, there has been a significant effort to adapt the technology in tissue regeneration and drug delivery. ...
  • Biomaterial Selection for Tooth Regeneration
    Zhenglin Yuan, Hemin Nie, Shuang Wang, Chang Hun Lee, Ang Li, Susan Y. Fu, Hong Zhou, Lili Chen, Jeremy J. Mao
    Tissue Engineering, Part B: Reviews
    Tissue Engineering, Part B: Reviews Biomaterials are native or synthetic polymers that act as carriers for drug delivery or scaffolds for tissue regeneration. When implanted in ...
  • Harnessing Systems Biology Approaches to Engineer Functional...
    Lauren S. Sefcik, Jennifer L. Wilson, Jason A. Papin, Edward A. Botchwey
    Tissue Engineering, Part B: Reviews
    on increasing neovascularization via the delivery of a single growth factor or gene. ... that might enable the prediction of drug targets and whether or not activation of ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll